celastrol has been researched along with Angiogenesis, Pathologic in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, D; Feng, H; Guo, Z; Li, J; Li, Z; Zhang, J; Zhu, L | 1 |
| Kong, X; Li, H; Ni, H; Ouyang, J; Zhao, W | 1 |
| He, P; Huang, S; Li, J; Peng, X; Tang, Y; Xu, D | 1 |
| Bai, S; Deng, Q; Gao, W; Tong, L | 1 |
| Chamcheu, JC; Mukhtar, H; Pala, N; Sanna, V; Sechi, M; Siddiqui, IA | 1 |
| Dai, Y; DeSano, JT; Ji, Q; Lawrence, TS; Ljungman, M; Meng, Y; Xu, L | 1 |
| Aggarwal, BB; Liu, M; Lu, B; Pang, X; Qu, W; Sung, B; Yi, Z; Zhang, J | 1 |
| Huang, L; Li, Q; Ren, J; Wu, G; Zeng, H; Zhang, R; Zhang, S; Zhang, Z | 1 |
| Jiang, Z; Li, H; Mu, X; Shi, W; Sun, L; Zhang, L | 1 |
| Cai, X; Huang, S; Liu, X; Pan, T; Peng, X; Tang, Y; Wang, D; Wang, X; Xiang, Y; Zhang, L | 1 |
| Tang, D; Tao, X | 1 |
| Aggarwal, BB; Ahn, KS; Pandey, MK; Sethi, G | 1 |
1 review(s) available for celastrol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[Advances in the study of tumor angiogenesis and anti-angiogenic Chinese herbal drugs].
Topics: Angiogenesis Inhibitors; Animals; Bufanolides; Drugs, Chinese Herbal; Ginsenosides; Glucans; Humans; Neoplasms; Neovascularization, Pathologic; Pentacyclic Triterpenes; Phytotherapy; Plants, Medicinal; Polysaccharides; Triterpenes | 2003 |
11 other study(ies) available for celastrol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles.
Topics: Angiogenesis Inhibitors; Animals; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Female; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Micelles; Nanoparticles; Neovascularization, Pathologic; Pentacyclic Triterpenes; Retinal Neoplasms; Retinoblastoma; Solubility; Triterpenes; Xenograft Model Antitumor Assays | 2020 |
Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation.
Topics: Active Transport, Cell Nucleus; Angiogenesis Inhibitors; Cell Division; Cell Line, Tumor; Cell Movement; Culture Media, Conditioned; Down-Regulation; Human Umbilical Vein Endothelial Cells; Humans; I-kappa B Kinase; I-kappa B Proteins; Lipopolysaccharides; Molecular Structure; Multiple Myeloma; Neovascularization, Pathologic; NF-kappa B; NF-KappaB Inhibitor alpha; Pentacyclic Triterpenes; Toll-Like Receptor 4; Transcription Factor RelA; Transcription, Genetic; Triterpenes; Vascular Endothelial Growth Factor A; Wound Healing | 2014 |
Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs.
Topics: AC133 Antigen; Aged; Animals; Antigens, CD; Bone Marrow Cells; Bone Neoplasms; Cell Line, Tumor; Endothelial Cells; Glycoproteins; Humans; Hyaluronan Receptors; Male; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Middle Aged; Neoplastic Stem Cells; Neovascularization, Pathologic; Nitric Oxide Synthase Type III; Pentacyclic Triterpenes; Peptides; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Triterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Pristimerin inhibits angiogenesis in adjuvant-induced arthritic rats by suppressing VEGFR2 signaling pathways.
Topics: Angiogenesis Inhibitors; Angiopoietin-1; Animals; Arthritis, Experimental; Cell Movement; Cell Proliferation; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neovascularization, Pathologic; Pentacyclic Triterpenes; Rats; Rats, Sprague-Dawley; Signal Transduction; Synovial Membrane; Triterpenes; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment.
Topics: Apoptosis; Calorimetry, Differential Scanning; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Endocytosis; Humans; Male; Microscopy, Confocal; Nanoparticles; Neovascularization, Pathologic; Particle Size; Pentacyclic Triterpenes; Prostatic Neoplasms; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Static Electricity; Triterpenes | 2015 |
Celastrol potentiates radiotherapy by impairment of DNA damage processing in human prostate cancer.
Topics: Animals; Apoptosis; Caspase 3; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Radiation; Enzyme Activation; Female; Flow Cytometry; Histones; Humans; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Pentacyclic Triterpenes; Prostatic Neoplasms; Radiation-Sensitizing Agents; Random Allocation; Triterpenes; Xenograft Model Antitumor Assays | 2009 |
Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Chemotaxis; Endothelial Cells; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Pentacyclic Triterpenes; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Specific Pathogen-Free Organisms; TOR Serine-Threonine Kinases; Triterpenes; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2010 |
Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1α pathway.
Topics: Antineoplastic Agents; Cell Hypoxia; Drug Screening Assays, Antitumor; Hep G2 Cells; HSP90 Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Pentacyclic Triterpenes; Plant Roots; RNA, Messenger; RNA, Neoplasm; Tripterygium; Triterpenes; Vascular Endothelial Growth Factor A | 2011 |
Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Aorta, Thoracic; Cell Line, Tumor; Cell Movement; Chick Embryo; Female; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; Pentacyclic Triterpenes; Rats; Rats, Sprague-Dawley; Signal Transduction; Triterpenes; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2012 |
Celastrol inhibits vasculogenesis by suppressing the VEGF-induced functional activity of bone marrow-derived endothelial progenitor cells.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bone Marrow Cells; Cell Survival; Cells, Cultured; Chemotaxis; Endothelium, Vascular; Humans; Microvessels; Middle Aged; Neovascularization, Pathologic; Nitric Oxide Synthase Type III; Pentacyclic Triterpenes; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Stem Cells; Triterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2012 |
Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents, Phytogenic; Apoptosis; Base Sequence; Cell Line; Cell Line, Tumor; Cell Proliferation; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; I-kappa B Proteins; MAP Kinase Kinase Kinases; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; NF-kappa B; NF-KappaB Inhibitor alpha; Pentacyclic Triterpenes; Phosphorylation; Triterpenes; Tumor Necrosis Factor-alpha | 2007 |